Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:33 AM
Ignite Modification Date:
2025-12-26 @ 10:33 AM
NCT ID:
NCT04349228
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of COVID-19 (-)
* Works in a medical intensive care unit exposed to COVID-19 infection
* 18 years old \< age \< 65 years old
* Having given written consent for their participation in the study.
Exclusion Criteria:
* Diagnosis of COVID-19+
* Retinopathies,
* Hydroxychloroquine or other prophylactic treatments for VIDOC19 within one month prior to inclusion and throughout the study.
* Hypersensitivity to chloroquine or hydroxychloroquine or 4-aminoquinolines or any of the other components of this drug,
* Contraindication to prophylactic use of chloroquine, e.g. liver failure, known epilepsy, creatinine clearance \< 30 ml/min.
* Inability to be monitored during the trial period
* Pregnancy and breastfeeding
* Psoriasis
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04349228
Study Brief:
Protocol Section:
NCT04349228